Research and Markets added report named as “Global Exoskeleton System Market 2015-2019″ to their offering. The key vendors include EKSO BIONICS HOLDING (OTCBB:EKSO), Cyberdyne, Rewalk Robotics Ltd(NASDAQ:RWLK) and Rex Bionics. As per the report, the global exoskeleton system industry is expected to grow at CAGR of 72.51% between 2014 and 2019. Apart from this, the FDA for the first time approved ReWalk Exoskeleton for public and in-home use by paraplegics. Prior to this, its use was confined to physical therapy and medical offices.
The news can provide a catalyst for the exoskeleton sector as the technology becomes available to the general public. The development also places EKSO BIONICS HOLDING (OTCBB:EKSO) on the front foot as it becomes a more attractive takeover target of big companies. The big names who are looking to benefit from growing exoskeleton market needs exclusive control of critical technology. Only after that they will be able to excel in the industry.
The big companies including Boston Dynamics can get intellectual property from firms like EKSO BIONICS HOLDING (OTCBB:EKSO). Here, intellectual property means software that controls movement of Exoskeleton suits. The technology that Ekso has is far superior to what is used by Boston Dynamics. Boston Dynamics, which was acquired by Google (NASDAQ:GOOG) can look to acquire Ekso so as to get control of critical technology. As a second option, the company can enter into a long-term licensing agreement with Ekso that would result in long-term revenue for small cap company.
The long-term benefits
The arrangement between Ekso and Boston Dynamics puts light on the acquisition objective of Boston by Google. The internet company has made an aggressive and bold entry into advanced robotics industry. With the acquisition, Google is well-positioned to benefit from growing exoskeleton industry.
It can be defined as a man-machine system that combines machine power and human intelligence, thereby enabling users to gain strength to move or walk.